This invention provides a
protein chip for early warning of
liver cancer and its application. The
protein chip includes an
antigen set; the
antigen set includes antigens; the antibodies corresponding to the antigens are at least one of 61 selected from GNA11, GNAS, IDH1, MSH2, NPM1, PAX5, PTCH1,
PTEN, SRSF2,
Survivin, CAST, PAIP1, PRKCZ, RAD23A, RUNX1T1, SARS, TP53, APEX2, RCSD1, and AIF1; the
protein chip is used for early warning assessment of
liver cancer, and the early warning assessment steps include: collecting serum from the
target population, using the
protein chip to detect the serum to obtain detection data, and then determining whether they belong to a low-risk, medium-risk, or high-risk
population based on a risk warning model; the
protein chip systematically detects tumor-related
autoantibody risk factor signals using high-
throughput technology for early warning detection of
liver cancer.